BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2020 2:50:53 PM | Browse: 835 | Download: 1420
 |
Received |
|
2020-03-18 16:52 |
|
Peer-Review Started |
|
2020-03-18 16:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-05-15 23:47 |
|
Revised |
|
2020-06-18 16:16 |
|
Second Decision |
|
2020-06-22 10:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-06-23 01:21 |
|
Articles in Press |
|
2020-06-23 01:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-30 12:46 |
|
Publish the Manuscript Online |
|
2020-07-07 14:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Matteo Tardelli |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Matteo Tardelli, MSc, PhD, Lecturer, Postdoctoral Fellow, Division of Gastroenterology and Hepatology, Joan and Sanford I Weill Cornell Department of Medicine, Weill Cornell Medical College, 413 E. 69th Street, New York, NY 10013, United States. mat4005@med.cornell.edu |
| Key Words |
Lipid metabolism; Monoacylglycerol lipase; Non-alcoholic steatohepatitis; Non-alcoholic fatty liver disease; Cannabinoid; Nuclear receptors |
| Core Tip |
Monoacylglycerol lipase inhibition/modulation is yet unappreciated however attractive therapeutic concept to limit liver disease as fatty acids may drive hepatocyte injury, fibrogenesis and change immune cells phenotype. |
| Publish Date |
2020-07-07 14:50 |
| Citation |
Tardelli M. Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease. World J Gastroenterol 2020; 26(25): 3577-3585 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i25/3577.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i25.3577 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
